(Q43997770)

English

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

28 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Paul T McSorley

1

1 reference

Europe PubMed Central

28 November 2017

Patrick M Bell

2

1 reference

Europe PubMed Central

28 November 2017

Lisbeth Vestergård Jacobsen

3

1 reference

Europe PubMed Central

28 November 2017

Allan Kristensen

4

1 reference

Europe PubMed Central

28 November 2017

Anders Lindholm

5

1 reference

Europe PubMed Central

28 November 2017

publication date

1 April 2002

1 reference

Europe PubMed Central

28 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

28 November 2017

24

1 reference

Europe PubMed Central

28 November 2017

4

1 reference

Europe PubMed Central

28 November 2017

530-539

1 reference

Europe PubMed Central

28 November 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Do insulin-treated diabetic patients use an injection-meal-interval in daily life?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Monomeric insulins obtained by protein engineering and their medical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin analogs with improved pharmacokinetic profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Noncompartmental versus compartmental modelling in clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-action profile of the insulin analogue B28Asp

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Injection-meal interval: recommendations of diabetologists and how patients handle it.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985129-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)85129-3

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43997770&oldid=2105441859"